Squarepoint
IART icon

Squarepoint’s Integra LifeSciences IART Stock Holding History

Squarepoint’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-62,372
Closed -$765K – 4629
2025
Q2 		$765K Buy
+62,372
New +$906K ﹤0.01% 2901
2025
Q1 		– Sell
-25,285
Closed -$573K – 4951
2024
Q4 		$573K Sell
25,285
-64,458
-72% -$1.41M ﹤0.01% 3613
2024
Q3 		$1.63M Buy
+89,743
New +$2.08M ﹤0.01% 2214
2024
Q2 		– Sell
-12,993
Closed -$461K – 4327
2024
Q1 		$461K Sell
12,993
-26,150
-67% -$1.05M ﹤0.01% 3102
2023
Q4 		$1.7M Buy
+39,143
New +$1.54M ﹤0.01% 2122
2023
Q3 		– Sell
-6,647
Closed -$273K – 3996
2023
Q2 		$273K Sell
6,647
-5,127
-44% -$247K ﹤0.01% 3023
2023
Q1 		$676K Buy
+11,774
New +$663K ﹤0.01% 2129
2022
Q3 		– Sell
-4,698
Closed -$254K – 3181
2022
Q2 		$254K Buy
+4,698
New +$282K ﹤0.01% 2359
2022
Q1 		– Sell
-5,976
Closed -$400K – 3149
2021
Q4 		$400K Buy
+5,976
New +$404K ﹤0.01% 2298
2021
Q2 		– Sell
-19,597
Closed -$1.35M – 3437
2021
Q1 		$1.35M Buy
19,597
+2,471
+14% +$167K 0.01% 1296
2020
Q4 		$1.11M Buy
17,126
+4,685
+38% +$252K 0.01% 1264
2020
Q3 		$587K Buy
12,441
+2,542
+26% +$121K 0.01% 1310
2020
Q2 		$465K Buy
+9,899
New +$487K 0.01% 1352
2020
Q1 		– Sell
-29,106
Closed -$1.7M – 2152
2019
Q4 		$1.7M Buy
29,106
+20,929
+256% +$1.25M 0.01% 1003
2019
Q3 		$491K Sell
8,177
-30,273
-79% -$1.8M ﹤0.01% 1626
2019
Q2 		$2.15M Buy
38,450
+31,233
+433% +$1.61M 0.02% 805
2019
Q1 		$402K Sell
7,217
-58,016
-89% -$2.95M ﹤0.01% 1600
2018
Q4 		$2.94M Buy
65,233
+50,333
+338% +$2.76M 0.03% 558
2018
Q3 		$981K Sell
14,900
-136,174
-90% -$8.46M 0.01% 997
2018
Q2 		$9.73M Buy
151,074
+118,946
+370% +$7.37M 0.13% 232
2018
Q1 		$1.78M Buy
+32,128
New +$1.68M 0.03% 613

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint's IART Position: Q3 2025 in Review

Squarepoint sold out of Integra LifeSciences (IART) in Q3 2025, closing a stake of 62,372 shares — an estimated $765K sold.

Squarepoint first reported a position in IART in Q1 2018 and held it in 21 quarters. The position peaked at $9.73M in Q2 2018. 207 funds tracked by Wall St. Rank hold IART as of Q3 2025.

  • Squarepoint reported no remaining Integra LifeSciences position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 62,372 Integra LifeSciences shares in Q3 2025, an estimated $765K.
  • Squarepoint first reported a position in Integra LifeSciences in Q1 2018 and held it in 21 quarters.
  • Squarepoint's Integra LifeSciences position peaked at $9.73M in Q2 2018.
  • 207 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.